We are live on ! Find out more
MDGSW

Medigus Ltd. Series C Warrant
MDGSW

Delisted

MDGSW was delisted on the 19th of July, 2023.

Back to rankings

4 hedge funds and large institutions have $144K invested in Medigus Ltd. Series C Warrant in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

92% less capital invested

Capital invested by funds: $1.8M → $144K (-$1.66M)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.45K
2
AFM
Anson Funds Management
Texas
+$2.59K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.53M
2
SM
Sabby Management
Florida
-$10.7K
3
CH
CVI Holdings
Delaware
-$482

MDGSW Hedge Fund Activity: Q3 2019 in Review

4 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q3 2019, worth a combined $144K — down 92% from $1.8M a quarter earlier.

Fund positioning in MDGSW was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $6.45K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.53M sold.

  • 4 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $144K of Medigus Ltd. Series C Warrant stock for Q3 2019, down 92% quarter-over-quarter.
  • 1 fund opened new Medigus Ltd. Series C Warrant positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Medigus Ltd. Series C Warrant buyer in Q3 2019 was Susquehanna International Group, an estimated $6.45K added.
  • The largest Medigus Ltd. Series C Warrant seller in Q3 2019 was Armistice Capital, an estimated $1.53M sold.

Based on aggregated 13F filings for Q3 2019.